Press & media resources.
Everything you need to cover Basion and the genetic disease space.
Media contact.
For press inquiries, interviews, or expert commentary on genetic disease policy and technology, contact our communications team.
press@basion.ai →Brand assets.
Logos, brand guidelines, and approved imagery for use in media coverage. Please use assets as provided without modification.
Brand kit available upon request.
About Basion.
Basion is the first platform built for life with genetic disease. We help patients and caregivers organize medical records, track symptoms, find clinical trials, and navigate insurance access for high-cost therapies.
For pharmaceutical companies, foundations, and payers, Basion provides the trust infrastructure for real-world evidence, patient engagement, and outcomes measurement in genetic disease.
Basion covers 7,000+ genetic conditions, serving the 300 million people worldwide affected by genetic disease — 95% of whom have no FDA-approved treatment.
Press releases.
Coming soon.
Press releases will be published here as they become available.